Drugs / Licensed COVID-19 Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06821061 Comparator | Feb → Dec 2025 | COVID-19, influenza | BioNTech SE | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Licensed COVID-19 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06821061 ↗ |
| Modality | Vaccine | “Licensed COVID-19 Vaccine” NCT06821061 ↗ |